What is the current Price Target for the Disc Medicine stock?

The average Disc Medicine target price is $91.80. This is 7.21% higher than the current stock price. The highest price target is 61.86%, the lowest is 0.26%. 13 Analysts have issued a price target Disc Medicine 2026 .

How high will the Disc Medicine stock rise?

No reliable answer can be given as to how high the Disc Medicine stock will rise. The performance of stocks, including the Disc Medicine stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Disc Medicine stock today?

The performance of Disc Medicine stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Disc Medicine stock fall?

The decline in Disc Medicine stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Disc Medicine Forecast, price target & analysts

$85.63

2.32%

NYSE, Oct 24, 10:00 pm CET

ISIN

US2546041011

Symbol

IRON

Reports

Quarter | Annual

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Dividends Analysts Charts Strategies

Disc Medicine Target price 2025 - Analyst rating & recommendation

Disc Medicine Classifications & Recommendation:

Buy

94%

Hold

Disc Medicine Price Target

Target Price	$91.80
Price	$85.63
Potential	7.21% register free of charge
Number of Estimates	13

	13 Analysts have issued a price target Disc Medicine 2026 . The average Disc Medicine target price is $91.80. This is 7.21% register free of charge higher than the current stock price. The highest price target is $138.60 61.86% register free of charge , the lowest is $85.85 0.26% register free of charge .
	A rating was issued by 18 analysts: 17 Analysts recommend Disc Medicine to buy, 1 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Disc Medicine stock has an average upside potential 2026 of 7.21% register free of charge . Most analysts recommend the Disc Medicine stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-3.96	-5.74
	15.79%	44.95%
P/E		negative

14 Analysts have issued a Disc Medicine forecast for earnings per share. The average Disc Medicine EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-3.96	15.79%
2025	$-5.74 44.95% Unlock
2026	$-6.42 11.85% Unlock
2027	$-5.52 14.02% Unlock
2028	$-3.50 36.59% Unlock
2029	$-0.41 88.29% Unlock
2030	$4.11 1,102.44% Unlock
2031	$7.72 87.83% Unlock
2032	$11.23 45.47% Unlock

Current	-20.63	40.80%
2025	-14.93 27.64% Unlock
2026	-13.33 10.72% Unlock
2027	-15.51 16.35% Unlock
2028	-24.44 57.58% Unlock
2029	-209.25 756.18% Unlock
2030	20.82 109.95% Unlock
2031	11.10 46.69% Unlock
2032	7.63 31.26% Unlock

Disc Medicine...

Current Disc Medicine Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
Wedbush	Locked ➜ Locked	Locked	Oct 17 2025
Raymond James	Locked ➜ Locked	Locked	Oct 17 2025
Cantor Fitzgerald	Locked ➜ Locked	Locked	Oct 17 2025
Morgan Stanley	Locked ➜ Locked	Locked	Aug 18 2025
Truist Securities	Locked ➜ Locked	Locked	Jul 21 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Jul 03 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Jun 17 2025

Analyst Rating	Date
Locked Wedbush: Locked ➜ Locked	Oct 17 2025
Locked Raymond James: Locked ➜ Locked	Oct 17 2025
Locked Cantor Fitzgerald: Locked ➜ Locked	Oct 17 2025
Locked Morgan Stanley: Locked ➜ Locked	Aug 18 2025
Locked Truist Securities: Locked ➜ Locked	Jul 21 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Jul 03 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Jun 17 2025

Discover more stocks with a high price target

TUI 50.73%

Deutsche Telekom 33.66%

Netflix 32.31%

BioNTech SE - ADR 32.25%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now